Data item | Fluoxetine | Placebo |
---|---|---|
Age (years (mean, SD)) | ||
Gender (male %) | ||
Ethnicity | ||
Marital status | ||
Living arrangements | ||
Employment | ||
Independent in everyday activities before the stroke | ||
Patient consented for themselves | ||
Co-morbidities (existing) | ||
Previous ischaemic stroke/TIA | ||
Previous intracranial bleeding | ||
Known coronary heart disease | ||
Current depression | ||
Past depression | ||
Known diabetes mellitus | ||
Previous upper gastrointestinal bleeding | ||
Current or past hyponatraemia (Na < 130 mmol/L) | ||
Previous bone fractures | ||
Status at enrolment | ||
NIHSS (median, IQR) | ||
Motor deficit present on NIHSS | ||
Aphasia present on NIHSS | ||
Ability to lift both arms | ||
Ability to walk alone | ||
Able to talk and not confused (GCS speech normal) | ||
Patient health questionnaire (PHQ) | ||
Haemorrhage on brain imaging? | ||
OCSP classification for ischaemic stroke | ||
Modified TOAST classification |